Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/25/2024 | $130.00 → $125.00 | Outperform → Sector Perform | RBC Capital Mkts |
| 9/13/2024 | $130.00 → $125.00 | Buy → Neutral | Citigroup |
| 8/2/2024 | $136.00 → $127.00 | Buy → Hold | Jefferies |
| 7/29/2024 | $151.00 → $126.00 | Buy → Neutral | BofA Securities |
| 7/25/2024 | $133.00 → $126.00 | Outperform → In-line | Evercore ISI |
| 7/24/2024 | $140.00 → $130.00 | Outperform → Neutral | Wedbush |
| 1/30/2024 | $140.00 | Buy | Deutsche Bank |
| 10/11/2023 | $108.00 | Neutral | Exane BNP Paribas |
Wedbush analyst Richard Anderson downgrades Alexandria Real Estate (NYSE:ARE) from Outperform to Neutral and lowers the price target from $140 to $130.
Existing home sales in the United States plunged 5.4% in June 2024 from the previous month, marking the steepest monthly drop since November 2022. This decline is attributed to heightened buyer apprehension, as the median sales price reached a record high for the second consecutive month. In June 2024, sales totaled 3.89 million units, a decrease from 4.11 million in May, according to data released Tuesday by the National Association of Realtors (NAR). Year-over-year, sales also fell by 5.4%. The median existing-home price for all housing types in June was $426,900, an all-time high and an increase of 4.1% from $410,100 a year ago. Total housing inventory at the end of June was 1.3
RBC Capital Mkts downgraded Alexandria RE from Outperform to Sector Perform and set a new price target of $125.00 from $130.00 previously
Citigroup downgraded Alexandria RE from Buy to Neutral and set a new price target of $125.00 from $130.00 previously
Jefferies downgraded Alexandria RE from Buy to Hold and set a new price target of $127.00 from $136.00 previously
PASADENA, Calif., Oct. 21, 2024 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced financial and operating results for the third quarter ended September 30, 2024. Key highlights YTD Operating results 3Q24 3Q23 3Q24 3Q23 Total revenues: In millions $ 791.6 $ 713.8 $ 2,327.4 $ 2,128.5 Growth 10.9 % 9.3 % Net income attributable to Alexandria's common stockholders – diluted: In millions $ 164.7 $ 21.9 $ 374.5 $ 184.4 Per share $ 0.96 $ 0.13 $ 2.18 $ 1.08 Funds from operations attributable to Alexandria's common stockholders – diluted, as adjusted: In mi
PASADENA, Calif., Sept. 4, 2024 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) today announced that its Board of Directors declared a quarterly cash dividend of $1.30 per common share for the third quarter of 2024. The dividend is payable on October 15, 2024 to stockholders of record on September 30, 2024. The common stock dividend for the 12 months ending September 30, 2024 of $5.14 per common share represents an increase of 24 cents, or 5 percent, over the 12 months ended September 30, 2023. The dividend allows the company to share its continued high-qualit
PASADENA, Calif., Sept. 3, 2024 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) today announced that the company will conduct a conference call and audio webcast on Tuesday, October 22, 2024, at 3:00 p.m. Eastern Time (ET), in conjunction with the release of its third quarter 2024 operating and financial results. Alexandria will release its operating and financial results after the market closes on Monday, October 21, 2024. To participate in this conference call, dial (833) 366-1125 (U.S.) or (412) 902-6738 shortly before 3:00 p.m. ET and ask the operator to j
SC 13G/A - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Subject)
SC 13G/A - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Subject)
SC 13G/A - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Subject)
4 - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Issuer)
4 - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Issuer)
4 - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Issuer)
Alexandria to lead mission-critical panel on immunology and inflammation as a cornerstone of treating human disease tomorrow at the 2024 Galien Forum USA at the Alexandria Center® for Life Science – New York City PASADENA, Calif., Nov. 6, 2024 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative mega campuses in AAA life science innovation cluster locations, continues to leverage its position at the vanguard and heart of the $5 trillion secularly growing life science industry to foster the development of new therapies and cures for the 10,000 diseases known to humankind, of whic
PASADENA, Calif., Oct. 21, 2024 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced financial and operating results for the third quarter ended September 30, 2024. Key highlights YTD Operating results 3Q24 3Q23 3Q24 3Q23 Total revenues: In millions $ 791.6 $ 713.8 $ 2,327.4 $ 2,128.5 Growth 10.9 % 9.3 % Net income attributable to Alexandria's common stockholders – diluted: In millions $ 164.7 $ 21.9 $ 374.5 $ 184.4 Per share $ 0.96 $ 0.13 $ 2.18 $ 1.08 Funds from operations attributable to Alexandria's common stockholders – diluted, as adjusted: In mi
PASADENA, Calif., Sept. 30, 2024 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative mega campuses in AAA life science innovation cluster locations, today announced it has been named by Newsweek as one of the World's Most Trustworthy Companies in 2024. This significant distinction builds on Alexandria's recognition by the publication as one of America's Most Trustworthy Companies in 2023 and 2024. Alexandria was selected for this prestigious annual list based on the analysis of an extensive independent survey, compiled in collaboration with Newsweek's market research partner Sta
8-K - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Filer)
10-Q - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Filer)
8-K - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Filer)